Advertisement
Screener

AGENUS INC (AGEN) Material Contracts, 2017

AGENUS INC Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2017-08-07: Form 10-Q; Exhibit 10.1; Description DEVELOPMENT AND MANUFACTURING SERVICES AGREEMENT.
  • 2017-05-04: Form 10-Q; Exhibit 10.4; Description Consulting Agreement dated as of April 1, 2017 by and between Agenus Inc. and Dr. Robert Stein. Filed herewith..
  • 2017-05-04: Form 10-Q; Exhibit 10.3; Description Separation Agreement dated as of April 1, 2017 by and between Agenus Inc. and Dr. Robert Stein. Filed herewith..
  • 2017-05-04: Form 10-Q; Exhibit 10.1; Description FIRST AMENDMENT TO.
FiledFormExhibitDescription
2017-08-0710-Q10.1DEVELOPMENT AND MANUFACTURING SERVICES AGREEMENT
2017-05-0410-Q10.4Consulting Agreement dated as of April 1, 2017 by and between Agenus Inc. and Dr. Robert Stein. Filed herewith.
2017-05-0410-Q10.3Separation Agreement dated as of April 1, 2017 by and between Agenus Inc. and Dr. Robert Stein. Filed herewith.
2017-05-0410-Q10.1FIRST AMENDMENT TO
2017-03-1610-K10.16Employment Agreement dated March 10, 2017 between Agenus Inc. and Dr. Jean-Marie Cuillerot. Filed herewith.

Similar stocks

Stock NameCountryMarket CapPE Ratio
C4 Therapeutics, Inc. (CCCC)United States$0.373B-5.65
FENNEC PHARMACEUTICALS INC. (FENC)United States$0.371B-115.85
Surrozen, Inc./DE (SRZN)United States$0.395B
Zura Bio Ltd (ZURA)$0.398B-6.56
Artiva Biotherapeutics, Inc. (ARTV)United States$0.367B
Cabaletta Bio, Inc. (CABA)United States$0.365B-2.81
Scribe Therapeutics, Inc. (SCTX)United States$0.410B
Ocugen, Inc. (OCGN)United States$0.343B-6.34
Editas Medicine, Inc. (EDIT)United States$0.424B-4.29
Kyverna Therapeutics, Inc. (KYTX)United States$0.434B-3.60